---
title: "AI Hype Meets Reality: Fringe Stocks' Desperate Bets on Laser Radar and Robotaxis"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/303531972.md"
description: "Microcaps are leveraging AI narratives amid thin fundamentals: AEYE's NASA deal contrasts with losses, KIDZ's Robotaxi bid on minimal revenue draws skepticism, ZNB plunges post-breach, while AXA warns of AI risks even as it bets on the technology."
datetime: "2026-10-29T09:18:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/303531972.md)
  - [en](https://longbridge.com/en/news/303531972.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/303531972.md)
generator: "portal-rs"
---

# AI Hype Meets Reality: Fringe Stocks' Desperate Bets on Laser Radar and Robotaxis

While Wall Street obsesses over AI's next frontier, a clutch of microcaps are weaponizing the buzzword with increasingly desperate gambits. AEYE Inc (LIDR.US) touts NASA-backed lunar missions and counter-drone contracts, yet its $202,000 Q2 revenue barely covers three weeks of R&D burn. The optics worsen when Kidz AI (KIDZ.US) — posting $481,831 in quarterly sales — nonchalantly submits a non-binding offer for 500 Tesla Robotaxis, prompting Electrek to label it “a zombie company's crypto-style narrative play.”

AXA (AXAHY.US) exemplifies the cognitive dissonance: its Future Risks Report 2026 identifies AI as the top global threat, yet the insurer pledges €25 billion in AI-driven growth. Meanwhile, BioAge Labs (BIOA.US) quietly doses its NLRP3 inhibitor in diabetic eye trials while Zeta Network (ZNB.US) implodes from a data breach that erased 40% of its value in weeks. The pattern repeats — Procept Robotics (PRCT.US) faces shareholder lawsuits over alleged revenue inflation even as it extends debt maturities.

Not all narratives are hollow. Trilogy Metals (TMQ.US) secured $35.6 million from the Department of War for Arctic mining development, while CK Hutchison (CKHUY.US) deployed asset-sale proceeds into Watsons Plus retail innovation. But for every credible pivot, two stocks like BT Brands (BTBD.US) — which scrapped a drone-related merger after SEC delays — reveal how thin the line is between strategic repositioning and survival theater.

### Related Stocks

- [LIDR.US](https://longbridge.com/en/quote/LIDR.US.md)
- [TMQ.US](https://longbridge.com/en/quote/TMQ.US.md)
- [CKHUY.US](https://longbridge.com/en/quote/CKHUY.US.md)
- [ZNB.US](https://longbridge.com/en/quote/ZNB.US.md)
- [IDCBY.US](https://longbridge.com/en/quote/IDCBY.US.md)
- [AXAHY.US](https://longbridge.com/en/quote/AXAHY.US.md)
- [KIDZ.US](https://longbridge.com/en/quote/KIDZ.US.md)
- [GMED.US](https://longbridge.com/en/quote/GMED.US.md)
- [BIOA.US](https://longbridge.com/en/quote/BIOA.US.md)
- [PSIG.US](https://longbridge.com/en/quote/PSIG.US.md)
- [BTBD.US](https://longbridge.com/en/quote/BTBD.US.md)
- [PRCT.US](https://longbridge.com/en/quote/PRCT.US.md)

## Related News & Research

- [PROCEPT BioRobotics (PRCT) Could Be 61% Undervalued After Earnings And Guidance Reaffirmation](https://longbridge.com/en/news/305354858.md)
- [Globus Medical Director James R. Tobin Reports $3.13 Million Common Share Disposal](https://longbridge.com/en/news/305382992.md)
- [Globus Medical Director Sold Shares Worth Over $3.1M](https://longbridge.com/en/news/305383671.md)
- [Globus Medical to Present at Jefferies Global Healthcare Conference](https://longbridge.com/en/news/304906827.md)
- [Globus Medical Stock Earnings Beat Meets Lower Revenue Outlook and Bigger Buyback](https://longbridge.com/en/news/304720887.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**